Track: Advances and Latest trends on diabetic research

Session Overview

Novel Drug Targets and Therapeutic Agents: Research is identifying new molecular targets involved in glucose regulation and insulin sensitivity. These discoveries are leading to the development of innovative drug therapies with improved efficacy and safety. Such agents aim to address both glycemic control and diabetes-related complications.

Precision Medicine and Personalized Diabetes Care: Personalized approaches tailor treatment based on individual genetic, metabolic, and lifestyle factors. This strategy improves treatment response and minimizes adverse effects. Precision medicine supports more effective and patient-centered diabetes management.

Advances in Insulin Therapy and Delivery Systems: Recent innovations have improved insulin formulations and delivery methods. Technologies such as insulin pumps, smart pens, and automated insulin delivery systems enhance glycemic control. These advances help reduce hypoglycemia and improve patient convenience.

Role of Genetics, Epigenetics, and Biomarkers: Genetic and epigenetic research provides insight into diabetes susceptibility and disease progression. Biomarkers help in early diagnosis, risk prediction, and treatment monitoring. These tools support targeted and timely therapeutic interventions.

Digital Health, AI, and Technology in Diabetes Research: Digital platforms and artificial intelligence are reshaping diabetes care and research. They enable continuous glucose monitoring, data-driven decision-making, and remote patient management. Technology-driven solutions improve adherence, outcomes, and healthcare efficiency.

6th Global Meeting on Diabetes and Endocrinology

Track: Advances and Latest trends on diabetic research

Scientific Highlights

Organization Location

Mail us at

Our Social Presence

Call us at